Belgian College of Neuropsychopharmacology and Biological Psychiatry 

Ilse Smolders

Bibliography

1/ Full-length papers in PubMed-cited international peer-reviewed journals


2013

- Van Liefferinge J, Massie A, Portelli J, Di Giovanni G, Smolders I.
Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?
Front Cell Neurosci. 2013 Aug 30;7:139. Review.
SCI Impactfactor  2012 = 4.469.

- Loyens E, De Bundel D, Demaegdt H, Chai SY, Vanderheyden P, Michotte Y, Gard P, Smolders I.
Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase
Int J Neuropsychopharmacol. 16 (2013) 1153-1163.
SCI Impactfactor  2012 = 5.641.

- Gómez-Galán M, De Bundel D, Van Eeckhaut A, Smolders I, Lindskog M.
Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression.
Molecular Psychiatry. 18 (2013) 582-594.
SCI Impactfactor 2012 = 14.897.

- Afrikanova T, Serruys AS, Buenafe OE, Clinckers R, Smolders I, de Witte PA, Crawford AD, Esguerra CV.
Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs.
PLoS One. 2013;8(1):e54166. doi: 10.1371/journal.pone.0054166. Epub 2013 Jan 14.
SCI Impactfactor  2012 = 3.730.

- Schallier A, Vermoesen K, Loyens E, Van Liefferinge J, Michotte Y, Smolders I, Massie A.
L-Theanine intake increases threshold for limbic seizures but decreases threshold for generalized seizures.
Nutr Neurosci. 16 (2013):78-82.
SCI Impactfactor  2012 = 1.647.

- Burguière A, De Bundel D, Valjent E, Roger J, Smolders I, Fagni L, Perroy J.
Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
Neuropharmacology. 66 (2013) 151-157.
SCI Impactfactor  2012 = 4.114.

- Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P.
The Cystine/Glutamate Antiporter System xc- in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities. Review.
Antioxid Redox Signal. 18 (2013) 522-555.
SCI Impactfactor  2012 = 7.189.

- Brouwers S, Smolders I, Massie A, Dupont AG.
Angiotensin II Type 2 Receptor-Mediated and Nitric Oxide-Dependent Renal Vasodilator Response to Compound 21 Unmasked by Angiotensin-Converting Enzyme Inhibition in Spontaneously Hypertensive Rats In Vivo.
Hypertension. 62 (2013) 920-926
SCI Impactfactor 2012 = 6.873
2012

- Portelli J, Thielemans L, Ver Donck L, Loyens E, Coppens J, Aourz N, Aerssens J, Vermoesen K, Clinckers R, Schallier A, Michotte Y, Moechars D, Collingridge GL, Bortolotto ZA, Smolders I.
Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents.
Neurotherapeutics 9 (2012) 658-672.
SCI Impactfactor  = 5.904.

- Portelli J, Michotte Y, Smolders I.
Ghrelin: An emerging new anticonvulsant neuropeptide. Review.
Epilepsia. 53 (2012) 585-595.
SCI Impactfactor = 3.909.

- Vermoesen K, Massie A, Smolders I, Clinckers R.
The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy.
Epilepsia. 53 (2012) 870-878
SCI Impactfactor  = 3.909.

- Loyens E, Vermoesen K, Schallier A, Michotte Y, Smolders I.
Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors.
Brain Res. 1436 (2012) 43-50.
SCI Impactfactor = 2.879.

- Meurs A, Portelli J, Clinckers R, Balasubramaniam A, Michotte Y, Smolders I.
Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation.
Neurosci Lett. 510 (2012) 143-147.
SCI Impactfactor = 2.026.

- Caljon G, Caveliers V, Lahoutte T, Stijlemans B, Ghassabeh G, Van Den Abbeele J, Smolders I, De Baetselier P, Michotte Y, Muyldermans S, Magez S, Clinckers R.
Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.
Br J Pharmacol. 165 (2012) 2341-2353.
SCI Impactfactor = 5.069.

2011

- D. De Bundel, A. Schallier, E. Loyens, R. Fernando, H. Miyashita, K. Vermoesen, J. Van Liefferinge, S. Bannai, H. Sato, Y. Michotte, I. Smolders#, A. Massie# (#equally contributing senior authors)
Loss of system xc- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility.
J. Neurosci. 31 (2011) 5792-5803.
SCI impactfactor = 7.115

- N. Aourz, D. De Bundel, B. Stragier, R. Clinckers, J. Portelli, Y. Michotte, I. Smolders.
Rat hippocampal somatostatin sst(3) and sst(4) receptors mediate anticonvulsive effects in vivo: Indications of functional interactions with sst(2) receptors.
Neuropharmacology. 61 (2011) 1327-1333.
SCI impactfactor = 4.814

- E. Loyens, A. Schallier, S.Y. Chai, D. De Bundel, P. Vanderheyden, Y. Michotte, I. Smolders.
Deletion of insulin-regulated aminopeptidase in mice decreases susceptibility to pentylenetetrazol-induced generalized seizures.
Seizure. 20 (2011) 602-605
SCI impactfactor = 1.798

- K. Vermoesen, A.S. Serruys, E. Loyens, T. Afrikanova, A. Massie, A. Schallier, Y. Michotte, A.D.  Crawford, C.V. Esguerra, P.A. de Witte, I. Smolders, R. Clinckers.
Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models.
Epilepsy Behav. 22 (2011) 450-460.
SCI impactfactor = 2.335

- R. Raedt, R. Clinckers, L. Mollet, K. Vonck, R. El Tahry, T. Wyckhuys, V. De Herdt, E. Carrette, W. Wadman, Michotte Y, Smolders I, Boon P, Meurs A.
Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation (VNS) in a limbic seizure model.
J Neurochem.  57 (2011) 956-964.
SCI impactfactor = 4.061

- A. Schallier, I. Smolders, D. Van Dam, E. Loyens, P.P. De Deyn, A. Michotte, Y. Michotte, A. Massie. Region- and age-specific changes in glutamate transport in the APP23 mouse model for Alzheimer’s disease.
J Alzheimers Dis  24 (2011) 287-300.
SCI impactfactor = 3.745

- A. Van Eeckhaut, K. Maes, N. Aourz, I. Smolders, Y. Michotte
The absolute quantification of endogenous levels of brain neuropeptides in vivo using LC–MS/MS
Bioanalysis 3 (2011) 1271-1285.
SCI impactfactor = 3.223

- C. Meissirel, C. Ruiz de Almodovar, E. Knevels, C. Coulon, N. Chounlamountri, I. Segura, P. de Rossi, S. Vinckier, K. Anthonis, B. Deléglise, M. de Mol, C. Ali, K. Dassonville, E. Loyens, J. Honnorat, Y. Michotte, V. Rogemond, I. Smolders, T. Voets, D. Vivien, P. Vanden Berghe, L. Van den Bosch, W. Robberecht, A. Chédotal, S. Oliviero, M. Dewerchin, D. Schmucker, N. Thomasset, P. Salin, P. Carmeliet.
VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation.
Proc Natl Acad Sci U S A. 108 (2011) 13782-13787.
SCI impactfactor = 9.681

- A. Massie, A. Schallier, K. Seong-Woong, H. Beck, D. De Bundel, K. Vermoesen, S. Bannai, I. Smolders, M. Conrad, N. Plesnila, H. Sato, Y. Michotte.
Dopaminergic neurons of system xc- deficient mice are protected against 6-OHDA induced neurodegeneration.
FASEB J  25 (2011) 1359-1369.
SCI impactfactor = 5.712

- R. Yang, I. Smolders, P. Vanderheyden, H. Demaegdt, A. Van Eeckhaut, G. Vauquelin, A. Lukaszuk, D. Tourwé, S.Y. Chai, A.L. Albiston, C. Nahmias, T. Walther, A.G. Dupont
Pressor and renal hemodynamic effects of the novel angiotensin A peptide are AT1a receptor dependent
Hypertension  57 (2011) 956-664.
SCI impactfactor = 6.207

- R. Yang, I. Smolders, A.G. Dupont.
Blood pressure and renal hemodynamic effects of angiotensin fragments. Review.
Hypertension Res  34 (2011) 674-683.
SCI impactfactor = 2.576

2010

- Clinckers R, Zgavc T, Vermoesen K, Meurs A, Michotte Y, Smolders I.
Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures.
J Neurochem. 115 (2010) 1595-607.
5-year SCI impactfactor = 4.206

- Vermoesen K, Smolders I, Massie A, Michotte Y, Clinckers R.
The control of kainic acid-induced status epilepticus.
Epilepsy Res. 90 (2010) 164-6.
5-year SCI impactfactor = 2.669

- D. De Bundel, N. Aourz, F. Kiagiadaki, R. Clinckers, D. Hoyer, A. Kastellakis, Y. Michotte, K. Thermos, I. Smolders.
Hippocampal sst(1) receptors are autoreceptors and do not affect seizures in rats.
NeuroReport 21 (2010) 254-258.
5-year SCI impactfactor 2008 = 2.260

- D. De Bundel, H. Demaegdt, T. Lahoutte, V. Caveliers, K. Kersemans; A.G. Ceulemans, G. Vauquelin, R. Clinckers, P. Vanderheyden, Y. Michotte, I. Smolders.
Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV-haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory.
J Neurochem. 112 (2010) 1223-1234.
5-year SCI impactfactor = 4.206

- G. Laureys, R. Clinckers, S. Gerlo, A. Spooren, N. Wilczak, R. Kooijman, I. Smolders, Y. Michotte, J. De Keyser.
Astrocytic beta(2)-adrenergic receptors: From physiology to pathology. Review.
Prog Neurobiol. 91 (2010) 189-99.
5-year SCI impactfactor  = 11.554

- R. Yang, T. Walther, F. Gembardt, I. Smolders, P. Vanderheyden, A.L. Albiston, S.Y. Chai, A.G. Dupont.
Renal vasoconstrictor and pressor responses to angiotensin IV in mice are AT1a-receptor mediated.
J Hypertens. 28 (2010) 487-494.
5-year SCI impactfactor = 4.487

- B. Bosier, S. Sarre, I. Smolders, Y. Michotte, E. Hermans,D.M. Lambert.
Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.
Neuropharmacology. 59 (2010) 503-10.
5-year SCI impactfactor = 3.824


2009
- A. Schallier, A. Massie, E. Loyens, D. Moechars, Y. Michotte & I. Smolders.
VGLUT2 heterozygous mice are more susceptible to pentylenetetrazole-induced seizures.
Neurochem. Int. 55 (2009) 41-44.  
SCI impactfactor = 3.541

- J. Portelli, N. Aourz, D. De Bundel, A. Meurs, I. Smolders, Y. Michotte, R. Clinckers.
Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats.
Epilepsy Res. 87 (2009) 234-246.
SCI impactfactor = 2.479

- R. Clinckers, I. Smolders, K. Vermoesen, Y. Michotte, M. Danhof, R. Voskuyl, O. Della Pasqua.
Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations.
Expert Opin Drug Metab Toxicol. 5 (2009) 1267-1277. Review.
SCI impactfactor = 3.076

- D. De Bundel, I. Smolders, A.L. Albiston, Y. Michotte & S.Y. Chai.
IRAP inhibitors enhance spatial working memory: effects on extracellular hippocampal glucose levels.
Neurobiol Learn Mem. 92 (2009) 19-26.
SCI impactFactor  = 3.479

- A. Van Eeckhaut, K. Lanckmans, S. Sarre, I. Smolders & Y. Michotte.
Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects.
J Chromatogr B Analyt Technol Biomed Life Sci. 877 (2009) 2198-2207. Review.
SCI impactfactor  = 2.777

- V. Umbrain, MH. Lauwers, L. Shi, I. Smolders, Y. Michotte & J. Poelaert.  
Comparison of the effects of intrathecal administration of levobupivacaine and lidocaine on the prostaglandin E2 and glutamate increases in cerebrospinal fluid: a microdialysis study in freely moving rats.
Br J Anaesth. 102 (2009) 540-5.
SCI impactfactor = 3.827
 
- V. Umbrain, I. Smolders, J. Poelaert.
Is Intrathecal lidocaine administration risk-free in rats with neuropathic pain? Reply to [Effects of intrathecal lidocaine on hyperalgesia and allodynia following chronic constriction injury in rats. Eur J Pain 13 (2009) 130-137].
Eur J Pain. 13 (2009) 890; author reply 891.
SCI impactfactor = 3.612

- A.G. Dupont, R. Yang, I. Smolders & P. Vanderheyden.
IRAP and AT(1) receptor mediated effects of angiotensin IV.
J Intern Med. 265 (2009) 401-103; letter to the editor.
SCI impactfactor = 5.942

2008
- I. Smolders, R. Clinckers, A. Meurs, D. De Bundel, J. Portelli, G. Ebinger & Y. Michotte.
Hippocampal dopamine and serotonin as potential biomarkers for predicting combined antidepressant-anticonvulsant action of ionotropic and metabotropic glutamate receptor ligands
Neuropharmacology 54 (2008) 1017-1028.
SCI impactfactor = 3.383

- R. Clinckers, I. Smolders, Y. Michotte, G. Ebinger, R. Voskuyl, M. Danhof & O. Della Pasqua.
Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.
Brit. J. Pharmacol. 155 (2008) 1127-1138.
SCI impactfactor = 4.902

- A. Meurs, R. Clinckers, G. Ebinger, Y. Michotte & I. Smolders.
Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin.
Epilepsy Res. 78 (2008) 50-59.
SCI impactfactor = 2.405

- D. De Bundel, S. Sarre, A. Van Eeckhaut, I. Smolders & Y. Michotte.
Critical evaluation of acetylcholine determination in rat brain microdialysates using ion-pair liquid chromatography with amperometric detection
Sensors 8 (2008) 5171-5185.
SCI impactfactor = 1.870

- D. De Bundel, I. Smolders, P. Vanderheyden & Y. Michotte.
 Ang II and Ang IV: Effects on synaptic plasticity, learning, memory, seizures and epilepsy.
CNS Neurosci. Ther. 14 (2008) 315-339. Review
SCI impactfactor= 3.795

- R. Yang, I. Smolders, D. De Bundel, R. Fouyn, H. Demaeghdt, P. Vanderheyden & A.G. Dupont.
Brain and peripheral AT1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
J. Hypertens. 26 (2008) 998-1007.
SCI impactfactor = 5.132

- A. Massie, A. Schallier, B. Mertens, K. Vermoesen, S. Bannai, H. Sato, I. Smolders & Y. Michotte.
Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.
Neuroreport 19 (2008) 1589-1592.
SCI impactfactor = 1.904

- A. Massie, L. Cnops, I. Smolders, R. McCullumsmith, R. Kooijman, S. Kwak, L. Arckens & Y. Michotte.
High-affinity Na+/K+-dependent glutamate transporter EAAT4 is expressed throughout the rat fore- and midbrain.
J Comp Neurol. 511 (2008) 155-172.
SCI impactfactor = 3.743

- K. Lanckmans, S. Sarre, I. Smolders & Y. Michotte.
Quantitative LC-MS for the analysis of microdialysates. Review.
Talanta 74 (2008) 458-469.
SCI impact factor = 3.206

- V. Umbrain, L. Shi, MH. Lauwers, I. Smolders, Y. Michotte & F. Camu.
Intrathecal lidocaine elevates prostaglandin E2 levels in cerebrospinal fluid: a microdialysis study in freely moving rats.
Br J Anaesth. 101 (2008) 716-722.
SCI impact factor = 2.920

- B. Stragier, D. De Bundel, S. Sarre, I. Smolders, G. Vauquelin, A.G. Dupont, Y. Michotte & P. Vanderheyden.
Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV. Invited review.
Heart Fail. Rev. 13 (2008) 321-337.
SCI impactfactor = 4.015



2007

- A. Meurs, R. Clinckers, G. Ebinger, Y. Michotte & I. Smolders.
Sigma 1 Receptor-Mediated Increase in Hippocampal Extracellular Dopamine Contributes to the Anticonvulsant Mechanism of Action of Neuropeptide Y.
Eur. J. Neurosci. 26 (2007) 3079-3092
SCI impactfactor= 3.673

- A. Meurs, R. Clinckers, G. Ebinger, Y. Michotte & I. Smolders.
Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy. Invited Review.
Curr. Top. Med.Chem. 7 (2007) 1660-74
SCI impact factor = 4.325

- K. Lanckmans, B. Stragier, S. Sarre, I. Smolders & Y. Michotte.
Nano-LC-MS/MS for the monitoring of angiotensin IV in rat brain microdialysates: Limitations and possibilities.
J. Sep. Sci. 30 (2007) 2217-2224.
SCI impact factor = 2.632

- B. Stragier, H. Demaegdt, D. De Bundel, I. Smolders, S. Sarre, G. Vauquelin, G. Ebinger, Y. Michotte & P. Vanderheyden.
Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.
Brain Res. 1131 (2007) 97-105
SCI impact factor = 2.218
- K. Lanckmans, S. Sarre, I. Smolders & Y. Michotte.
Use of a structural analogue versus a stable isotopically labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano liquid chromatography-tandem mass spectrometry.*
Rapid Comm Mass Spectrom 21 (2007) 1187-1195
SCI impact factor  = 2.971

2006
- A. Meurs, R. Clinckers, G. Ebinger, Y. Michotte & I. Smolders.
Not Hippocampus but Substantia Nigra is an Anticonvulsant Site of Action of Topiramate in the Focal Pilocarpine Model of Limbic Seizures.
Epilepsia 47 (2006) 1519-1535
SCI impactfactor = 3.526
- K. Lanckmans, A. Van Eeckhaut, S. Sarre, I. Smolders & Y. Michotte.
Capillary and nano liquid chromatography-tandem mass spectrometry for the quantification of small molecules in microdialysis samples: comparison with microbore dimensions.
J. Chomatogr. A 1131 (2006) 166-175
SCI impactfactor = 3.554
- B. Stragier, R. Clinckers, A. Meurs, D. De Bundel, S. Sarre, G. Ebinger, Y. Michotte & I. Smolders.
Involvement of the somatostatin-2 receptor in the anticonvulsant effect of Ang IV against pilocarpine-induced limbic seizures in rats.
J. Neurochem. 98 (2006) 1100-1113
SCI impactfactor = 4.260
- L. Shi, I. Smolders, V. Umbrain, M.H. Lauwers, S. Sarre, Y. Michotte, M. Zizi & F. Camu.
Peripheral inflammation modifies the effect of intrathecal IL-1 on spinal PGE2 production mainly through cyclooxygenase (COX)-2 activity. A spinal microdialysis study in freely moving rats.
Pain  120 (2006) 307-314
SCI impactfactor = 4.836
- K. Lanckmans, R. Clinckers, A. Van Eeckhaut, S. Sarre, I. Smolders & Y. Michotte.
Use of microbore LC-MS/MS for the quantification of oxcarbazepine and its active metabolite in rat brain microdialysis samples.
J. Chomatogr. B Analyt. Technol.Biomed. Life Sci. 831 (2006) 205-212
SCI impactfactor = 2.647
- W. Chen, K. Kerckhofs, M. Van de Casteele, I. Smolders, D. Pipeleers, L. Zhidong.
Glucose inhibits GABA release by pancreatic beta cells through an increase in GABA shunt activity.
Am. J. Physiol. Endocrinol. Metabol. 290 (2006) E494-E499
SCI impactfactor = 4.123

2005

- R. Clinckers, I. Smolders, A. Meurs, G. Ebinger & Y. Michotte.
Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
Neurosci. Lett. 390 (2005) 48-53
SCI impactfactor = 1.898

- R. Clinckers, S. Gheuens, I. Smolders, A. Meurs, G. Ebinger & Y. Michotte.
In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
Epilepsia 46 (2005) 828-836
SCI impactfactor = 3.227

- A. Van Hemelrijck, S. Sarre, I. Smolders & Y. Michotte.
Determination of amino acids associated with cerebral ischaemia in rat brain microdialysates using narrowbore liquid chromatography and fluorescence detection.
J. Neurosci. Meth. 144 (2005) 63-71
SCI impactfactor = 1.784

- R. Clinckers, I. Smolders, A. Meurs, G. Ebinger & Y. Michotte.
Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity.
J. Pharmacol. Exp. Ther. 314 (2005) 725-731
SCI impactfactor = 4.098

2004

- I. Smolders, H. Lindekens, R. Clinckers, A. Meurs, M.J. O’Neill, D. Lodge, G. Ebinger & Y.  Michotte.
In vivo modulation of extracellular glutamate and GABA levels and of limbic seizures by group I and II metabotropic glutamate receptor ligands.
J. Neurochem. 88 (2004) 1068-1077
SCI impactfactor = 4.824

- R. Clinckers, I. Smolders, A. Meurs, G. Ebinger & Y. Michotte.
Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.  
Neuropharmacology 47 (2004) 1053-1061
SCI impactfactor = 3.734

- S. Hachimi-Idrissi, A. Van Hemelrijck, A. Michotte, I. Smolders, S. Sarre, G. Ebinger, L. Huyghens & Y. Michotte.
Postischemic mild hypothermia reduces neurotransmitter release and astroglial cell proliferation during reperfusion after asphyxial cardiac arrest in rats.
Brain Res. 1019 (2004) 217-225
SCI impactfactor = 2.389

- R. Clinckers, I. Smolders, A. Meurs, G. Ebinger & Y. Michotte.
Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors.
J. Neurochem. 89 (2004) 834-843
SCI impactfactor = 4.824

2003
- A. Massie, L. Cnops, I. Smolders, K. Van Damme, E. Vandenbussche, F. Vandesande, U. Eysel & L. Arckens.
Extracellular GABA concentrations in area 17 of cat visual cortex during topographic map reorganization following binocular central retinal lesioning.
Brain Res. 976 (2003) 100-108
SCI impactfactor 2002 = 2.409

2002
- I. Smolders, Z.A. Bortolotto, V.R.J. Clarke, R. Warre, G.M. Khan, M.J. O’Neill, P.L. Ornstein, D. Bleakman, A.M. Ogden, B. Weiss, J.P. Stables, K.H. Ho, G. Ebinger, G.L. Collingridge, D. Lodge & Y. Michotte.
Antagonists of GLUK5-containing kainate receptors prevent pilocarpine-induced limbic seizures.
Nature Neurosci. 5 (2002) 796-804
SCI impactfactor  = 14.857

- G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont & P. Vanderheyden.
Editorial review: Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.
JRAAS  3 (2002) 195-204.
SCI impactfactor 2005 = 1.169

 - I. Smolders, C. Gousseau, S. Marchand, W. Couet, G. Ebinger & Y. Michotte.
Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not GABA levels in conscious rats.
Antimicrob. Agents Chemother. 46 (2002) 471-477
SCI impactfactor  = 4.215

2001

- I. Smolders, J. Van Loo, S. Sarre, G. Ebinger & Y. Michotte.
Effects of dietary sucrose on hippocampal serotonin release: a microdialysis study in the freely moving rat.
Br. J. Nutr. 86 (2001) 151-155
SCI impactfactor = 1.989

- G.M. Khan, I. Smolders, G. Ebinger & Y. Michotte.
2-chloro-N6-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats.
Neuropharmacology 40 (2001) 657-667
SCI impactfactor = 3.854

- L. Bogaert, M.J. O’Neill, J. Moonen, S. Sarre, I. Smolders, G. Ebinger & Y. Michotte.
The effects of LY393613, nimodipine and verapamil, in focal cerebral ischemia.
Eur. J. Pharmacol. 411 (2001) 71-83
SCI impactfactor = 2.164

2000

- G.M. Khan, I. Smolders, G. Ebinger & Y. Michotte.
Flumazenil prevents diazepam-elicited anticonvulsant action and concomitant attenuation of glutamate overflow.
Eur. J. Pharmacol. 407 (2000) 139-144
SCI impactfactor = 2.047

- H. Lindekens, I. Smolders, G.M. Khan, M. Bialer, G. Ebinger & Y. Michotte.
In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy.
Pharm. Res. 17 (2000) 1408-1413
SCI impactfactor = 2.847

- L. Bogaert, D. Scheller, J. Moonen, S. Sarre, I. Smolders, G. Ebinger & Y. Michotte.
Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model for focal cerebral ischemia.
Brain Res. 887 (2000) 266-275
SCI impactfactor = 2.302

- G.M. Khan, I. Smolders, G. Ebinger & Y. Michotte.
Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures.
Neuropharmacology 39 (2000) 2418-2432
SCI impactfactor = 4.176


1999
- Z.A. Bortolotto, V.R.J. Clarke, C.M. Delany, M.C.Parry, I. Smolders, M. Vignes, K.H. Ho, P. Miu, B.T. Brinton, R. Fantaske, A. Ogden, M. Gates, P.L. Ornstein, D. Lodge, D. Bleakman & G.L. Collingridge.
Kainate receptors are involved in synaptic plasticity.
Nature 402 (1999) 297-301
SCI impactfactor = 29.491

- G.M. Khan, I. Smolders, H. Lindekens, J. Manil, G. Ebinger & Y. Michotte.
Effects of diazepam on extracellular brain neurotransmitters in pilocarpine-induced seizures in rats.
Eur. J. Pharmacol. 373 (1999) 153-161
SCI impactfactor = 2.047

1998
- K. Thorré, S. Sarre, I. Smolders, G. Ebinger & Y. Michotte.
Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
Brain Res. 796 (1998) 107-116
SCI impactfactor = 2.150


1997
- R. Meeusen, I. Smolders, S. Sarre, K. De Meirleir, H. Keizer, M. Serneels, G. Ebinger & Y. Michotte.
Endurance training effects on striatal neurotransmitter release, an in vivo microdialysis study.
Acta Physiol. Scand. 159 (1997) 335-341
SCI impactfactor = 1.204

- S. Sarre, I. Smolders, K. Thorré, G. Ebinger & Y. Michotte.
Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus, a microdialysis study.
J. Neural Transm. 104 (1997) 1215-1228
S.C.I. impactfactor = 1.659

- I. Smolders, G.M. Khan, H. Lindekens, S. Prikken, C.A. Marvin, J. Manil, G. Ebinger & Y. Michotte.
Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, GABA and dopamine levels, a microdialysis-electrocorticography study in freely moving rats.
J. Pharmacol. Exp. Ther. 283 (1997) 1239-1248
SCI impactfactor = 3.227

- I. Smolders, G.M. Khan, J. Manil, G. Ebinger & Y. Michotte.
NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats using microdialysis.
Br. J. Pharmacol. 121 (1997) 1171-1179
SCI impactfactor = 3.619

- I. Smolders, L. Bogaert, G. Ebinger & Y. Michotte.
Muscarinic modulation of striatal dopamine, glutamate and GABA release, as measured with in vivo microdialysis.
J. Neurochem. 68 (1997) 1942-1948
SCI impactfactor = 4.234

- I. Smolders, K. Van Belle, G. Ebinger & Y. Michotte.
Hippocampal and cerebellar extracellular amino acid levels during pilocarpine-induced seizures in freely moving rats as measured by microdialysis.
Eur. J. Pharmacol. 319 (1997) 21-29
SCI impactfactor = 1.960

1996

- I. Smolders, S. Sarre, C. Vanhaesendonck, G. Ebinger & Y. Michotte.
Extracellular striatal dopamine and glutamate after decortication and kainate receptor stimulation, as measured by microdialysis.
J. Neurochem., 66 (1996) 2373-2380
SCI impactfactor = 4.219

1995

- I. Smolders, N. De Klippel, S. Sarre, G. Ebinger & Y. Michotte.
Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat.
Eur. J. Pharmacol., 284 (1995) 83-91
SCI impactfactor = 2.637

- I. Smolders, S. Sarre, G. Ebinger & Y. Michotte.
The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography.
J. Neurosci. Meth., 57 (1995) 47-53
SCI impactfactor = 1.815

1992
- S. Sarre, K. Van Belle, I. Smolders, G. Krieken & Y. Michotte.  
The use of microdialysis for the determination of plasma protein binding of drugs.
J. Pharm. Biomed. Anal., 10 (1992) 735-739
SCI impactfactor=0.840



2/ Chapters in books

1997
- I. Smolders, S. Sarre, G. Ebinger & Y. Michotte.
Microbore liquid chromatography analysis of amino acid transmitters.
Chapter 15 in "Methods in Molecular Biology: Neurotransmitter Methods", volume 72, edited by R.C. Rayne, Humana Press Inc., Totowa, NJ, USA, 1997, pg 197-204.  

- S. Sarre, K. Thorré, I. Smolders & Y. Michotte.
Microbore liquid chromatography analysis of monoamine transmitters.
Chapter 14 in "Methods in Molecular Biology: Neurotransmitter Methods", volume 72, edited by R.C. Rayne, Humana Press Inc., Totowa, NJ, USA, 1997, pg 185-196.

2007
- I. Smolders & Y. Michotte.
The use of microdialysis for the study of neurological disorders.
Chapter 5.3 in “Handbook of Microdialysis: Methods, Applications and Perspectives” (Series: Techniques in Behavioral Sciences and Neural Sciences, TBNS, Volume 16 ), edited by B.H.C. Westerink & T. Cremers, Elsevier Books, pg 435-453.

2011

- I. Smolders, R. Clinckers & Y. Michotte
Microdialysis as a tool to unravel neurobiological mechanisms of seizures and antiepileptic drug action.
Chapter 4.5. in “Applications of Microdialysis in Pharmaceutical Science” edited by T.H. Tsai, John Wiley and Sons Inc., pg 207-253.

- I. Smolders, G. Laekeman.
Neurobiologische en psychofarmacologische basiskennis.
Hoofdstuk 2 in het handboek “Psychofarmacotherapie” uitgegeven door Academia Press in opdracht van the Belgian College of Neuropsychopharmacology and Biological Psychiarty, in press.

PrintEmail

Didier Schrijvers

Bibliography

Schrijvers D., Baeken C., Sabbe B., De Raedt R. The impact of high frequency repetitive Transcranial Magnetic Stimulation on fine motor functions in medication resistant major depression. Neuropsychobiology, in press.
Destoop Marianne, Schrijvers Didier, De Grave Carmen, Sabbe Bernard, De Bruijn Ellen.- Better to give than to take? Interactive social decision-making in severe major depressive disorder
Journal of affective disorders - ISSN 0165-0327 - 137:1-3(2012), p. 98-105
Schrijvers Didier, Bollen Jos, Sabbe Bernard.- The gender paradox in suicidal behavior and its impact on the suicidal process
Journal of affective disorders - ISSN 0165-0327 - 138:1-2(2012), p. 19-26
Morrens Manuel, Schrijvers Didier, Sabbe Bernard.- Reactie op "Katatonie meten : welke schaal te kiezen?"
Tijdschrift voor psychiatrie - ISSN 0303-7339 - 53:7(2011), p. 499-501
Van Den Eede Filip, Moorkens Greta, Hulstijn Wouter, Maas Yvonne, Schrijvers Didier, Stevens Staci R., Cosyns Paul, Claes Stephan, Sabbe Bernard.- Psychomotor function and response inhibition in chronic fatigue syndrome. Psychiatry research - ISSN 0165-1781 -186:2/3(2011), p. 367-372
Baeken C., Schrijvers Didier, Sabbe Bernard, Vanderhasselt M.A., de Raedt R..- The impact of one HF-rTMS session on fine motor function in healthy female subjects : a comparison of stimulation over the left versus the right dorsolateral prefrontal cortex. Neuropsychobiology -ISSN 0302-282X - (2011),
Destoop Marianne, Schrijvers Didier, Van Den Eede Filip, Moorkens Greta, Sabbe Bernard.- Psychomotor functioning in chronic fatigue syndrome and major depressive disorder
European psychiatric review - ISSN 1758-1354 - 3:1(2010), p. 58-61
Sabbe Bernard, Dom Geert, Glazemakers Inge, Goethals Kris, Janssens Astrid, Morrens Manuel, Schrijvers Didier, Van Den Eede Filip, van Hecke Jan, Deboutte Dirk, Van West Dirk.- Research projects in the Collaborative Antwerp Psychiatric Research Institute. Psychiatria Danubina: an international multidisciplinary journal / Universitas Studiorum Zagrabiensis. Facultas Medica - ISSN 0353-5053 -22:S:1(2010), p. S95-S105
Schrijvers Didier, De Bruijn Ellen, Destoop Marianne, Hulstijn Wouter, Sabbe Bernard.- The impact of perfectionism and anxiety traits on action monitoring in major depressive disorder
Journal of neural transmission: basic neurosciences, neurology section, psychiatry section - ISSN 0300-9564 - 117:7(2010), p. 869-880
Schrijvers Didier.- Monitoring slow motions : action disturbances in major depressive disorder. Doctoral thesis.
Antwerpen: Universiteit Antwerpen, Faculteit Geneeskunde, 2009.- 226 p.
Schrijvers Didier, De Bruijn Ellen, Maas Yvonne J., Vancoillie Patrick, Hulstijn Wouter, Sabbe Bernard.- Action monitoring and depressive symptom reduction in major depressive disorder
International journal of psychophysiology - ISSN 0167-8760 - 71:3(2009), p. 218-224
Schrijvers Didier, Maas Yvonne J., Sabbe Bernard.- Effects of fluoxetine on fine motor performance in dysthymia: an 8-week, nonrandomized, open-label study
Clinical therapeutics - ISSN 0149-2918 - 31:1(2009), p. 123-129
Wichers M., Schrijvers Didier, Geschwind N., Jacobs N., Myin-Germeys I., Thiery E., Derom C., Sabbe Bernard, Peeters F., Delespaul Ph.,van Os J..- Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversity
Psychological medicine - ISSN 0033-2917 - 39:7(2009), p. 1077-1086
Schrijvers Didier, Maas Y.J., Pier M.P.B.I., Madani Y., Hulstijn Wouter, Sabbe Bernard.- Psychomotor changes in major depressive disorder during sertraline treatment
Neuropsychobiology - ISSN 0302-282X - 59:1(2009), p. 34-42
Schrijvers Didier, Van Den Eede Filip, Maas Y., Cosyns Paul, Hulstijn Wouter, Sabbe Bernard.- Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: a comparative study
Journal of affective disorders - ISSN 0165-0327 - 115:1/2(2009), p. 46-53
Schrijvers Didier, De Bruijn Ellen, Maas Yvonne, de Grave Carmen, Sabbe Bernard, Hulstijn Wouter.- Action monitoring in major depressive disorder with psychomotor retardation
Cortex - ISSN 0010-9452 - 44:5(2008), p. 569-579
Schrijvers Didier, Hulstijn Wouter, Sabbe Bernard.- Psychomotor symptoms in depression: a diagnostic, pathophysiological and therapeutic tool
Journal of affective disorders - ISSN 0165-0327 - 109:1/2(2008), p. 1-20

 

PrintEmail

Cornelis van Heeringen

Bibliography

International publications 2013-2014


Verhaeghe, Nick, Delphine De Smedt, Jan De Maeseneer, et al. “Cost-effectiveness of Health Promotion Targeting Physical Activity and Healthy Eating in Mental Health Care.” BMC PUBLIC HEALTH 14 (2014): n. pag. Print.

Wittouck, Ciska, Sara Van Autreve, Gwendolyn Portzky, et al. “A CBT-based Psychoeducational Intervention for Suicide Survivors.” CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION 35.3 (2014): 193–201. Print.

Bursztein Lipsicas, Cendrine, Ilkka Henrik Mäkinen, Danuta Wasserman, et al. “Immigration and Recommended Care After a Suicide Attempt in Europe: Equity or Bias?” EUROPEAN JOURNAL OF PUBLIC HEALTH 24.1 (2014): 63–65. Print.

Gibbs, Ayana A, Sirpreet K Somal, Ki Fung D Chan, et al. “Adrenergic Receptor Gene Variation and Selective Norepinephrine Reuptake Inhibitors.” AMERICAN JOURNAL OF PSYCHIATRY 170.4 (2013): 446–447. Print.

Vanslembrouck, M, Gwendolyn Portzky, and Cornelis Van Heeringen. “Suizidales Verhalten in Flandern (Belgien): Häufigkeit Und Präventionsstrategien.” SUIZIDPROPHYLAXE 152 (2013): 28–30. Print.

DESMYTER, STEFANIE, Stijn Bijttebier, and Cornelis Van Heeringen. “The Role of Neuroimaging in Our Understanding of the Suicidal Brain.” CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS 12.7 (2013): 921–929. Print.

Lipsicas, Cendrine Bursztein, Ilkka Henrik Mäkinen, Danuta Wasserman, et al. “Gender Distribution of Suicide Attempts Among Immigrant Groups in European Countries: An International Perspective.” EUROPEAN JOURNAL OF PUBLIC HEALTH 23.2 (2013): 279–284. Print.

Verhaeghe, Nick, Els Clays, Carine Vereecken, et al. “Health Promotion in Individuals with Mental Disorders: a Cluster Preference Randomized Controlled Trial.” BMC PUBLIC HEALTH 13 (2013): n. pag. Print.

Van Autreve, Sara, Wouter De Baene, Chris Baeken, et al. “Do Restrictive and Bingeing/purging Subtypes of Anorexia Nervosa Differ on Central Coherence and Set Shifting?” EUROPEAN EATING DISORDERS REVIEW 21.4 (2013): 308–314. Print.

Verhaeghe, Nick, Jan De Maeseneer, Lea Maes, et al. “Health Promotion in Mental Health Care: Perceptions from Patients and Mental Health Nurses.” JOURNAL OF CLINICAL NURSING 22.11-12 (2013): 1569–1578. Print.


International publications 2002-2012

Heylens G, Audenaert K, Van Heeringen C. Recreatief gebruik van stimulantia en hallucinogenen: situering en voorstellen voor farmacotherapeutische benadering van acute intoxicaties. Nederlands Tijdschrift voor Neurologie 2002, 5: 21-31.

Van Heeringen C , De Volder V. Trends in attempted suicide in adolescents and young adults, 1986-1995. Archives of Suicide Research 2002; 6: 135-143.

Audenaert K, Goethals I, Van Laere K, Lahorte P, Brans B, Versijpt J, Vervaet M, Beelaert L, Van Heeringen C, Dierckx R. SPECT neuropsychological activation procedure with the Verbal Fluency Test in attempted suicide patients. Nuclear Medicine Communications 2002; 23; 907-916

Peremans K, Audenaert K, Blanckaert P, Jacobs F, Coopman F, Verschooten F, Van Bree H, Van Heeringen C, Mertens J, Slegers G, Dierckx R. Effects of aging on brain perfusion and serotonin-2A binding in the normal canine brain measured with single photon emission compouterized tomography. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1393-1404.

Hjelmeland H, Hawton K, Nordvik H, De Leo D, Fekete S, Grad O, Haring C, Kerkhof A, Lönnqvist J, Michel K, Salander Renberg E, Schmidtke A, Van Heeringen C, Wasserman D. Why people engage in parasuicide: a cross-cultural study of intentions. Suicide and Life-Threatening Behavior 2002; 32: 380-393.

Goethals I, Audenaert K, Van de Wiele C, Van Laere K, Jacobs F, Vermeir G, Van Dierendonck A, van Heeringen C, Dierckx R. Toward the clinical application of neuropsychological activation probes with SPET: a novel spatial working memory task. J Nucl Med 2002; 43:1426-1431.

Vermeiren R, Schwab-Stone M,  Ruchkin V, King RA, van Heeringen C,  Deboutte D. Self-harming behavior and violence in male adolescents: a school-based study.  Journal of the American Association of Child and Adolescent Psychiatry 2003; 42:41-48.

Audenaert, K., Van Laere, K., Dumont, F., Vervaet, M., Goethals, I., Slegers, G., Mertens, J., Van Heeringen, C. & Dierckx, R. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. Journal of Nuclear Medicine, 2003;44: 163-169.

Vervaet, M., van Heeringen, C., & Audenaert, K. Psychological differences in Binge Eating Disorder and Bulimia Non-Purging patients. European Eating Disorders Review 2004;12 (1): 27-33.

Van Heeringen C. The neurobiology of suicide and suicidality. Can J Psychiatry 2003;48: 13-21.

Van Heeringen C, Marusic A. Understanding the suicidal brain. Br J Psychiatry 2003;183:282-284

Peremans K, Audenaert K, Coopman F, Blanckaert P, Jacobs F, Otte A, Verschooten F, van Bree H, van Heeringen C, Mertens J, Slegers G, Dierckx R. Estimates of regional cerebral blood flow and 5-HT2a receptor density in impulsive aggressive dogs with Tc-99m ECD and I-123 5-I-5 R91150. Eur J Nucl Med Mol Imaging 2003;30:1538-1546

Bir C, Bille-Brahe U, Cabecadas M, Chishti P, Corcoran P, Elgie E, van Heeringen C, Horte LG, Marchi AG, Ostamo A, Petridou E, Renberg ES, Stone DH, Wiik J, and Williamson E. Suicide mortality in the European Union. European Journal of Public Health, 2003;13:108-114.

Goethals I, Audenaert K, Jacobs F, Van de Wiele C, Pyck H, Ham H, Vandierendonck A, van Heeringen C, Dierckx R. Application of a neuropsychological activation probe with SPECT: the Tower of London task in healthy volunteers. Nucl Med Comm 2004; 25:177-182

Brans B, Van den Eynde F, Audenaert K, Vervaet M, Van Daele K, van Heeringen C, Dierckx R. Depression and anxiety during isolation and radionuclide therapy. Nucl Med Comm 2003;24: 881-886  

Vervaet, M., Audenaert K, van Heeringen C. Cognitive and behavioural characteristics are associated with personality dimensions in patients with eating disorders. European Eating Disorders Review 2003;11:363-379.


Audenaert K., Janssen HML, Otte A, Peremans K, Vervaet M, Crombez R, De Ridder L, Van Heeringen C, Thirot J, Dierckx R, Korf J. Imaging of mild traumatic brain injury using Cobalt-57 and Technetium-99m HMPAO SPECT as compared to other diagnostic procedures. Med Sci Mon 2003; 9(10): 112-117.
Chishti P, Stone DH, Corcoran P, Williamson E & EURSOAVE Working Group. Suicide mortality in the European Union. Eur J Public Health 2003;13:108-114.


Van Heeringen C. Unit for Suicide Research, University of Gent, Belgium. Br J Psychiatry 2003;193: 260-261.


Vervaet M, van Heeringen C, Audenaert K. Personality-related characteristics in restricting versus binging and purging eating disordered patients.  Comprehensive Psychiatry 2004;45: 37-43.  


Merlevede C, Spooren D, Henderick H, Portzky G, Buylaert W, Jannes C, Calle P, Van Staey M, De Rock C, Smeesters L, Michem N, Van Heeringen C. Perceptions, needs and mourning reactions of bereaved relatives confronted with a sudden unexpected death. Resuscitation 2004; 61: 341-348

Vervaet M, Audenaert K, van Heeringen C. Is drive for thinness in anorectic patients associated with personality characteristics? European Eating Disorders Review 2004;12: 1-5.

Van Heeringen C, Vincke J. Suicidal acts and ideation in homosexual and bisexual young people: a study of prevalence and risk factors. Social Psychiatry and Psychiatric Epidemiology 2004;35: 494-499.


Goethals I, Vervaet, M, Audenaert K, Van de Wiele C, Ham H, Vandecapelle M, Slegers G, Dierckx RA, van Heeringen C. Binding index of cortical 5-HT2a receptors is not different in bulimia nervosa patients versus healthy controls. American Journal of Psychiatry 2005, (10):1916-1918

Goethals I, Audenaert K, Jacobs F, Van den Eynde F, Bernagie K, Kolindou A, Vervaet M, Dierckx R, Van Heeringen C. Brain perfusion SPECT in impulsivity-related personality disorders. Behavioural Brain Research 2005; 157 (1): 187-192

Vincke J, van Heeringen C. Summerholiday camps for gay and lesbian young adults: an evaluation of their impact on social support and mental well-being. Journal of Homosexuality 2004;2: 33-47.

Peremans, K. Audenaert K, Y. Hoybergs, A. Otte, I. Goethals, I. Gielen, P. Blankaert, M. Vervaet, C. van Heeringen and R. Dierckx The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive–aggressive dog, as measured with 123I-5-I-R91150 SPECT.  J Nucl Med Mol Imaging 2005; 708-716

T’Sjoen GG, De Vos S, Goemaere S, Van Potelbergh I, Dierick M, van Heeringen C, Kaufman J-M. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 2005;53: 636-642.

De Fruyt F, De Clercq B, Van de Wiele L, van Heeringen C. The validity of Cloninger’s psychobiological model versus the Five-Factor Model to predict DSM-IV personality disorders in a heterogeneous psychiatric sample: domain, facet and residualized facet descriptions. J Personality 2006; 74; 479 - 510

Audenaert K, Peremans K, Goethals I, Otte A, Dierckx R, van Heeringen C. Functional imaging of the suicidal brain. Nuclear Medicine Communication 2005;26: 391-393.

Goethals I, Audenaert K, Van de Wiele C,, Jacobs F, Ham H, Pyck H,, Van Dierendonck A, van Heeringen C, Dierckx R. Blunted prefrontal perfusion in depressed patients performing the Tower of London task. Psychiatry Research: Neuroimaging 2005; 139:31-40.

Naudts K, Ducatelle C, Kovacs J, Lourens K, Peayy J, van den Eynde F, van Heeringen C. The role of psychiatrists in euthanasia in Belgium. Br J Psychiatry 2006; 188: 405-409

Portzky G, Audenaert K, van Heeringen C. Adjustment disorder and the course of the suicidal process in adolescents. Journal of Affective Disorders 2005, 87:265-270

Van den Eynde F, Naudts K, De Saedeleer S, van Heeringen C, Audenaert K. Olanzapine in Gilles de la Tourette syndrome: beyond tics. Acta Neurologica Belgica 2005; 105: 206-211.

Goethals I, Vervaet M, Audenaert K, Jacobs F, Ham H, Van de Wiele C, Vandecapelle M, Slegers G, Dierckx R, van Heeringen C. Differences of cortical 5-HT(2A) receptor binding index with SPECT in subtypes of anorexia nervosa: Relationship with personality traits? J Psychiatr Res 2007;41:455-458.

Portzky G, Audenaert K, van Heeringen C. Suicide among adolescents: a psychological autopsy study of psychiatric, psychosocial and personality-related risk factors. Social Psychiatry and Psychiatric Epidemiology 2005;40:922-930

KH Naudts, P Cosyns, T McInerny, K Audenaert, F Van den Eynde, C van Heeringen Belgium and its internees: a problem for human rights and a stimulus for service change. Criminal Behaviour and Mental Health 2005; 15(3):143-148

Peremans K, Goethals I, De Vos P, Ham H, Van Bree H, van Heeringen C, Audenaert K. SERT and DAT imaging in the canine brain. Nuclear Medicine and Biology 2006;33: 907-913

Portzky G, van Heeringen C. Suicide prevention in adolescents: a controlled study of the effectiveness of a school-based psycho-educational programme. Journal of Child Psychology and Psychiatry 2006;47: 910-918

McAuliffe C, Corcoran P, Keeley HS, Arensman E, Bille-Brahe U, De Leo D, Fekete S, Hawton K, Hjelmeland H, Kelleher M, Kerkhof AJFM, Lonnqvist J, Michel K, Solander-Renberg E, Schmidtke A, van Heeringen K, Wasserman D. Problem-solving ability and repetition of deliberate self-harm: a multicentre study. Psychological Medicine 2006; 36: 45-55.


van Heeringen C, Vandendriessche F, Gillain B, Van Vleymen B. The effect of using orally disintegrating olanzapine tablets on agitation, cooperation and nurses’ workload in psychiatric patients.  Acta Psychiatrica Belgica 2006, 106, 14-19.

De Fruyt F, De Clercq B, van de Wiele L, van Heeringen C. The validity of Cloninger's psychobiological model versus the five-factor model to predict DSM-IV personality disorders in a heterogeneous psychiatric sample: Domain facet and residualized facet descriptions. Journal of Personality 2006;74: 479-510.

Audenaert K, Peremans, K, Goethals I, van Heeringen C. Functional imaging, serotonin and the suicidal brain. Acta Neurologica Belgica 2006; 106:125-131.

Crane C, Williams M, Hawton K, Bille-Brahe U, Corcoran P, De Leo D, Fekete S, Grad O, Haring C, Kerkhof A, Lonnqvist J, Michel K, Salander Renberg E, Schmidtke A, van Heeringen C, Wasserman D. The association between life events and suicide intent in self-poisoners with and without a history of deliberate self-harm: a preliminary study. Suicide and Life-Threatening Behavior 2007;37:367-378 (IF 1.060)
86. Portzky G, van Heeringen C. Deliberate self-harm in adolescents. Current Opinions in Psychiatry 2007; 20:337-342.

Antretter E, Dunkel D, Haring C, Corcoran P, De Leo D, Fekete S, Hawton K, Kerkhof A, Lönnqvist J, Salander Renberg E, Schmidtke A, van Heeringen C, Wasserman D. The factorial structure of the Suicide Intent Scale: a comparative reexamination in clinical samples from 11 European regions. International Journal of Methods in Psychiatric Research 2008; 17: 63-79


Madge N, Hawton K, Arensman E, Ystgaard M, De Leo D, de Wilde EJ, Fekete S, van Heeringen C. The prevalence of deliberate self harm within an international community sample of young people: findings from the Child & Adolescent Self-harm in Europe (CASE) Study. Journal of Child Psychology and Psychiatry 2008;49(6): 667-677

Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. J Clin Psychopharmacology 2008;28: 147-155

Rossow I, Ystgaard M, Hawton K, Madge N, Hewitt A, van Heeringen C, de Wilde EJ, De Leo D, Fekete S, Morey C. Cross-national comparisons of the association between alcohol consumption and deliberate self-harm in adolescents. Suicide & Life-Threatening Behavior 2007; 37: 605-615

De Munck S, Van Rysselberghe L, Portzky G, van Heeringen C. The epidemiology of attempted suicide in Flanders. Crisis 2009;30:115-119.

Goethals I, Vervaet M, Audenaert K, Jacobs J, Ham H, van Heeringen C. Does regional brain perfusion correlate with eating disorder symptoms in anorexia and bulimia nervosa patients? Journal of Psychiatric Research 2007;41: 1005-1011.

Portzky G, De Wilde EJ, van Heeringen C. Deliberate self harm in young people: differences in prevalence and risk factors between the Netherlands and Belgium. European Journal of Child and Adolescent Psychiatry 2008;17: 179-186.

Hawton K, van Heeringen C. Suicide. The Lancet 2009;373: 1372-1381.

Ystgaard M, Arensman E, Hawton K, Madge N, van Heeringen C, de Wilde EJ, De Leo D, Fekete S. Deliberate self harm in adolescents: comparison between those who attend health care services following self harm and those who do not. Journal of Adolescence 2009;32:0875-891.

Scoliers G, Portzky G , Madge N, Hewitt A, Hawton K, de Wilde EJ, Ystgaard M, Arensman E, De Leo D, Fekete S, van Heeringen C. Reasons for adolescent deliberate self-harm: a Cry of Pain and/or a Cry for Help? Social Psychiatry and Psychiatric Epidemiology 2009;44: 601-607

Raes F, Dewulf D, van Heeringen C, Williams JMG. Mindfulness and reduced cognitive reactivity to sad mood: evidence from a correlational study and a non-randomized waiting list controlled study. Behaviour Research and Therapy 2009;47: 623-627

Van Heeringen C, Van den Abbeele D, Vervaet M, Soenen L, Audenaert K. The functional neuroanatomy of mental pain in depression.  Psychiatry Research: Neuroimaging 2010;181: 141-144.

Van den Eynde F, Senturk V, Vogels C, van Heeringen C, Audenaert K. Quetiapine treatment and improved cognitive functioning in borderline personality disorder. Human Psychopharmacology: Clinical and Experimental 2009;24:646-649.

Scoliers G, Portzky G, van Heeringen C, Audenaert K. Sociodemographic and psychopathological risk factors for repetition of attempted suicide: a 5-year follow-up study. Archives of Suicide Research 2009; 13:201-213.

Wittouck C, Portzky G, van Heeringen C. A comparative study of the implementation of a standardized tool for the psychosocial assessment of suicide attempters. Archives of Suicide Research 2010;14: 135-145.

Portzky G, Audenaert K, van Heeringen C. Psychosocial and psychiatric factors associated with adolescent suicide: A case-control psychological autopsy study. Journal of Adolescence 2009;32: 849-862.

Godfrin K, van Heeringen C. Mindfulness-based cognitive therapy: a randomized controlled trial of its effects on relapse/recurrence of depression, mental health and quality of life. Behaviour Research and Therapy 2010; 48: 738-746.

Sienaert P, Roelens Y, Demunter H, Van Steelandt K, Peuskens J, van Heeringen C.  Concurrent use of lamotrigine and electroconvulsive therapy. Journal of ECT 2011;27: 148-152.

Wittouck C, Van Autreve S, Portzky G, van Heeringen C. Can complicated grief be treated but not prevented? A systematic review of controlled trials. Clinical Psychology Review 2011;31: 69-78.


Van Heeringen C, Bijttebier S, Godfrin K. Suicidal brains: a systematic review of brain studies in association with suicidal behaviour. Neuroscience and Biobehavioral Reviews 2011; 35: 688-698.

Knops E, Lemmens G, van Heeringen C, Audenaert K. Investigation of early suicide-related symptoms in a non-suicidal depressed patient population after escitalopram administration: a pilot study. Internet Journal of Mental Health 2010; 6(2): 1-20.

Bursztein Lipsicas C, Mäkinen I H, Wasserman D, Apter A, DeLeo D, Kerkhof A, Lönnqvist J, Michel K, Salander Renberg E, Sayil I, Schmidtke A, van Heeringen C, Värnik A. Attempted suicide among immigrants in European countries – an international perspective. Social Psychiatry and Psychiatric Epidemiology 2012;47: 241-251.

Naudts KH, Azevedo RT, David AS, van Heeringen C & Gibbs AA.  Influence of COMT val158met and ADRA2B deletion polymorphisms on recollection and familiarity components of human emotional memory. Journal of Psychopharmacology 2012;26: 819-829.

Madge N, Hawton K, McMahon E, Corcoran P, De Leo D, De Wilde EJ, Fekete S, van Heeringen K, Ystgaard M, Arensman E. Psychological characteristics, stressful life events and deliberate self-harm: findings from the child and adolescent self-harm in Europe (CASE) study. Eur Child Adol Psych 2011; 10:499-508

Naudts K, Azevedo RT, David AS, van Heeringen K, Gibbs AA. Epistasis between 5-HTTLPR and ADRA2B polymorphisms on a cognitive marker of affective spectrum disorders. Int J Psychopharmacology (accepted for pub)

Demyttenaere K, Ansseau M, Constant E, Van Garssen G, Van Heeringen C. Do general practitioners and psychiatrists agree about defining cure from depression? The DESCRIBE survey. BMC Psychiatry 2011;11: 169.

Bursztein Lipsicas C, Mäkinen I H, Wasserman D, Apter A, DeLeo D, Kerkhof A, Lönnqvist J, Michel K, Salander Renberg E, Sayil I, Schmidtke A, van Heeringen C, Värnik A. Gender distribution of suicide attempts among immigrant groups in European countries: an international perspective. Social Psychiatry and Psychiatric Epidemiology 2012;2: 241-251.

Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Bogaert V, Claeys E, De Bacquer D, Annemans L. Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial. BMC Public Health 2013;13:657.

Brabant W, Mazure D, Vantilborgh A, van Heeringen C, Lemmens G. Agranulocytosis after cocaine use: a case of suspected levamisole contamination in Belgium.  Clinical Neurology and Neurosurgery 2013;114(8):1159-1160.

Bursztein Lipsicas C, Mäkinen I H, Wasserman D, Apter A, Kerkhof A, Michel K, Salander Renberg E, van Heeringen C, Värnik A, Schmidtke A. Repetition of attempted suicide among immigrants in Europe (in press)

Gibbs A, Somal SK, Chan KFD, Bautista CE, Mowlem F, Naudts K, van Heeringen C, Duka T. Adrenergic receptor gene variation and selective norepinephrine reuptake inhibitors. American Journal of Psychiatry 2013;170(4): 446-447.  

Vanslembrouck M, Portzky G, van Heeringen C. Suizidales Verhalten in Flandern (Belgien): Häufigkeit und Präventionsstrategien. Suizidprophylaxe 2013; 40, 28-30

Van Autreve S, De Baene W, Baeken C, Van Heeringen C, Vervaet M. Do restrictive and bingeing/purging subtypes of anorexia nervosa differ on central coherence and set shifting? European Eating Disorders Review 2013;21(4):308-314.

Bursztein Lipsicas C, Mäkinen I H, Wasserman D, Apter A, DeLeo D, Kerkhof A, Lönnqvist J, Michel K, Salander Renberg E, Sayil I, Schmidtke A, van Heeringen C, Värnik A. Immigration and recommended care after a suicide ttempt in Europe: equity or bias? European Journal of Public Health (e-pub ahead of print).

PrintEmail

Jacqueline Scuvée-Moreau

Bibliography

SCUVÉE-MOREAU J., LIÉGEOIS J.F., MASSOTTE L. and SEUTIN V. Methyl-laudanosine: a new pharmacological tool to investigate the function of small conductance Ca2+-activated K+ (SK) channels. J Pharmacol Exp Ther, 302, n° 2, 1176-1183, 2002. :http://hdl.handle.net/2268/2724

SCUVEE-MOREAU J., KURZ X., DRESSE A. and the NADES Group. The economic impact of demential in Belgium: results of the National Dementia Economic Study (NADES). Acta neurol. Belg., 102, 104-113, 2002. :http://hdl.handle.net/2268/31940  

LIEGEOIS J.-F., MERCIER F., GRAULICH A., GRAULICH-LORGE F., SCUVEE-MOREAU J. and SEUTIN V. Modulation of small conductance calcium-activated potassium (SK) channels : a new challenge in medicinal chemistry. Curr Med Chem 10 (8), 625-647, 2003. :http://hdl.handle.net/2268/2886; http://hdl.handle.net/2268/41464

KURZ X., SCUVEE-MOREAU J., VERNOOIJ-DASSEN M., DRESSE A. and the NADES Group. Cognitive impairment, dementia and quality of life. Acta neurol. belg., 103, 24-34, 2003.  http://hdl.handle.net/2268/34839

VERNOOIJ-DASSEN M., KURZ X., SCUVEE-MOREAU J. and DRESSE A. La mesure du sentiment de compétence chez les aidants de patients déments. Rev Epidémiol Sante Publique 51, 227-235, 2003  http://hdl.handle.net/2268/61022

KURZ X., SCUVEE-MOREAU J., RIVE B. and DRESSE A. A new approach to the qualitative evaluation of functional disability in dementia. Int J Geriatr Psychiatry 18, 1050-1055, 2003. http://hdl.handle.net/2268/61021

SCUVEE-MOREAU J,  BOLAND A, GRAULICH A, VAN OVERMEIRE L, D’HOEDT D, GRAULICH-LORGE F, THOMAS E, ABRAS A, STOCKER M, LIEGEOIS J-F and SEUTIN V. Electrophysiological characterization of the SK channel blockers methyl-laudanosine and methyl-noscapine in cell lines and rat brain slices. Br. J Pharmacol. 143, 753-764, 2004. http://hdl.handle.net/2268/5149, http://hdl.handle.net/2268/27824

GRAULICH A, MERCIER F, SCUVEE-MOREAU J, SEUTIN V and LIEGEOIS J.-F. ,Synthesis and Biological Evaluation of N-Methyl-Laudanosine Iodide Analogues as Potential SK Channel Blockers. Bioorg. Med. Chem. Vol 13/4 pp 1201-1209, 2005 http://hdl.handle.net/2268/2879;  http://hdl.handle.net/2268/27897

GRAULICH A , SCUVEE-MOREAU J, SEUTIN V and LIEGEOIS J-F. Synthesis and Radioligand Binding Studies of C-5 and C-8 Substituted 1-(3,4-Dimethoxybenzyl)-2,2-Dimethyl-1,2,3,4-tetrahydroisoquinoliniums as SK Channel Blockers Related to N-Methyl-Laudanosine and N-Methyl-Noscapine. J. Med. Chem. 48, 4972-4982, 2005 :http://hdl.handle.net/2268/2880; http://hdl.handle.net/2268/18782  

WAROUX O, MASSOTTE L, ALLEVA L, GRAULICH A, THOMAS E, LIEGEOIS J-F, SCUVEE-MOREAU J and SEUTIN V. SK channels control the firing pattern of midbrain dopaminergic neurons in vivo. European Journal of Neuroscience, vol 22, issue 12, 3111- 3121, 2005. http://hdl.handle.net/2268/5137;

HANSEN HH, EBBESEN C, MATHIESEN C, WEIKOP P, RONN LC, WAROUX O, SCUVEE-MOREAU J, SEUTIN V and MIKKELSEN JD. The KCNQ opener Retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. J Pharmacol Exp Ther 318, 1006-1019, 2006 http://hdl.handle.net/2268/2828;

GRAULICH A, SCUVEE-MOREAU J, ALLEVA L, LAMY C, WAROUX O, SEUTIN V and LIEGEOIS J-F. Synthesis and radioligand binding studies of methoxylated 1,2,3,4-tetrahydroisoquinolinium derivatives as ligands of the apamin-sensitive Ca2+- activated K+ channels , J Med Chem 49, 7208-7214, 2006  http://hdl.handle.net/2268/5135  

ANDRIEU S, RIVE B, GUILHAUME C, KURZ X, SCUVEE-MOREAU J, GRAND A and DRESSE A. New assessment of dependency in demented patients: impact on the quality of life in informal caregivers. Psychiatry and Clinical Neurosciences 61 (3), 234–242, 2007 http://hdl.handle.net/2268/60170

GRAULICH A, DILLY S, FARCE A, SCUVEE-MOREAU J, WAROUX O, LAMY C, CHAVATTE P, SEUTIN V, LIEGEOIS J-F Synthesis and radioligand binding studies of bis-isoquinolinium derivatives as small conductance Ca2+-activated K+ channel blockers  J Med Chem 2007, 50, 5070 - 5075 http://hdl.handle.net/2268/2888

DEFRAITEUR C., PLENEVAUX A., SCUVEE-MOREAU J., ROUCHET N., GOBLET D, LUXEN A. and SEUTIN V. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. Br J Pharmacol  152, 952-958, 2007  http://hdl.handle.net/2268/5146  

PHAN-BA R., SCUVEE-MOREAU J and SEUTIN V. Stratégies pharmacologiques de modulation de l'activité du système nerveux central. Rev Méd Liège vol 63, 5-6, 238-244, 2008  http://hdl.handle.net/2268/4799  

ROUCHET N., WAROUX O., LAMY C., MASSOTTE L., SCUVEE-MOREAU J., LIEGEOIS J.-F. and SEUTIN V. SK channel blockade promotes burst firing in dorsal raphe serotonergic neurons. European J Neuroscience, vol 28, 1108-1115, 2008. http://hdl.handle.net/2268/8940

DRION G, BONJEAN M, WAROUX O, SCUVEE-MOREAU J, LIEGEOIS JF, SEJNOWSKI TJ, SEPULCHRE R, SEUTIN V. M-type channels selectively control bursting in rat dopaminergic neurons Eur J Neurosci. 31, 827-835, 2010 http://hdl.handle.net/2268/6016  

LAMY C*, SCUVEE-MOREAU J*, DILLY S, LIEGEOIS J-F, SEUTIN V. The sigma agonist 1,3-di-o-tolylguanidine directly blocks SK channels in dopaminergic neurons and in cell lines. Eur J Pharmacol 641, 23-8. 2010 http://hdl.handle.net/2268/39330


•    *co-1ers auteurs

Sébastien Dilly, Jacqueline Scuvée-Moreau, Johan Wouters, Jean-François Liégeois The 5-HT1A agonism potential of substituted-piperazine-ethyl-amide derivatives is conserved in the hexyl homologues: molecular modeling and pharmacological evaluation in Journal of Chemical Information and Modeling 51, 2961-2966, 2011 http://hdl.handle.net/2268/99156

F Mangin, S Dilly, B Joly, J Scuvée-Moreau, J Evans, V Setola, B Roth, J-F Liégeois. Moderate chemical modulations of WAY100635 improve the selectivity for 5-HT1A versus D4 receptors Bioorganic & Medicinal Chemistry Letters, 22, 4550-4554, 2012 http://hdl.handle.net/2268/123901

 

PrintEmail

Chris Baeken

Bibliography

Published papers in peer-reviewed international journals 2013-2014

Baeken, Chris, Stephan Claes, and Rudi De Raedt. “The Influence of COMT Val158Met Genotype on the Character Dimension Cooperativeness in Healthy Females.” BRAIN AND BEHAVIOR (2014): n. pag. Print.


Baeken, Chris, Marie-Anne Vanderhasselt, Jonathan Remue, et al. “One Left Dorsolateral Prefrontal Cortical HF-rTMS Attenuates HPA-system Sensitivity to Critical Feedback in Healthy Females.” NEUROPSYCHOLOGIA 57 (2014): 112–121. Print.


Baeken, Chris, Daniele Marinazzo, Peter Van Schuerbeek, et al. “Left and Right Amygdala: Mediofrontal Cortical Functional Connectivity Is Differentially Modulated by Harm Avoidance.” PLOS ONE 9.4 (2014): n. pag. Print.


Baeken, Chris, Axel Bossuyt, and Rudi De Raedt. “Dorsal Prefrontal Cortical Serotonin 2A Receptor Binding Indices Are Differentially Related to Individual Scores on Harm Avoidance.” PSYCHIATRY RESEARCH-NEUROIMAGING 221.2 (2014): 162–168. Print.


Baeken, Chris, Daniele Marinazzo, Guorong Wu, et al. “Accelerated HF-rTMS in Treatment-resistant Unipolar Depression: Insights from Subgenual Anterior Cingulate Functional Connectivity.” WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 15.4 (2014): 286–297. Print.


Brunoni, André R, Chris Baeken, Rodrigo Machado-Vieira, et al. “BDNF Blood Levels After Electroconvulsive Therapy in Patients with Mood Disorders: a Systematic Review and Meta-analysis.” WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY 15.5 (2014): 411–418. Print.


Van Schuerbeek, Peter, Chris Baeken, Robert Luypaert, et al. “Does the Amygdala Response Correlate with the Personality Trait ‘Harm Avoidance’ While Evaluating Emotional Stimuli Explicitly?” BEHAVIORAL AND BRAIN FUNCTIONS 10 (2014): n. pag. Print

Herremans, SC, Marie-Anne Vanderhasselt, Rudi De Raedt, et al. “Reduced Intra-individual Reaction Time Variability During a Go-NoGo Task in Detoxified Alcohol-dependent Patients After One Right-sided Dorsolateral Prefrontal HF-rTMS Session.” ALCOHOL AND ALCOHOLISM 48.5 (2013): 552–557. Print.

Baeken, Chris, Marie-Anne Vanderhasselt, Jonathan Remue, et al. “Intensive HF-rTMS Treatment in Refactory Medication-resistant Unipolar Depressed Patients.” JOURNAL OF AFFECTIVE DISORDERS 151.2 (2013): 625–631. Print.

Aarts, Kristien, Marie-Anne Vanderhasselt, Georges Otte, et al. “Electrical Brain Imaging Reveals the Expression and Timing of Altered Error Monitoring Functions in Major Depression.” JOURNAL OF ABNORMAL PSYCHOLOGY 122.4 (2013): 939–950. Print.

Vanderhasselt, Marie-Anne, Chris Baeken, Peter Van Schuerbeek, et al. “How Brooding Minds Inhibit Negative Material: An Event-related fMRI Study.” BRAIN AND COGNITION 81.3 (2013): 352–359. Print.

Van Autreve, Sara, Wouter De Baene, Chris Baeken, et al. “Do Restrictive and Bingeing/purging Subtypes of Anorexia Nervosa Differ on Central Coherence and Set Shifting?” EUROPEAN EATING DISORDERS REVIEW 21.4 (2013): 308–314. Print.

Vanderhasselt, Marie-Anne, Chris Baeken, Peter Van Schuerbeek, et al. “Inter-individual Differences in the Habitual Use of Cognitive Reappraisal and Expressive Suppression Are Associated with Variations in Prefrontal Cognitive Control for Emotional Information: An Event Related fMRI Study.” BIOLOGICAL PSYCHOLOGY 92.3 (2013): 433–439. Print.

Published papers in peer-reviewed international journals until 2012


1. 123I5 I - R91150, a new SPECT ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. C.Baeken, H. D'haenen, P. Flamen, J. Mertens, D. Terriere, K. Chavatte, R. Boumon, and A. Bossuyt, European Journal of Nuclear Medicine (1998) 25:1617-1622. IF 2009 = 4.531

2.Lack of impact of repetitive High Frequency Transcranial Magnetic Stimulation on mood in healthy female subjects. Baeken C., Leyman L., De Raedt R., Vanderhasselt M.A. and D’haenen H. Journal of Affective Disorders. 2006; 90(1): 63-66.   IF 2009 = 3.763

3.The influence of rTMS over the left dorsolateral prefrontal cortex on Stroop task performance. Vanderhasselt MA, De Raedt R, Baeken C, Leyman L, D'haenen H. Exp Brain Res. 2006; 169(2): 279-282. IF 2009 = 2.256

4.The influence of rTMS over the right dorsolateral prefrontal cortex on intentional set switching. Vanderhasselt MA, De Raedt R, Baeken C, Leyman L, D'haenen H. Exp Brain Res. 2006; 172(4): 561-565. IF 2009 = 2.256

5.The influence of rTMS over the right dorsolateral prefrontal cortex on top-down attentional processes. Vanderhasselt MA, De Raedt R, Baeken C, Leyman L, Clerinx P, D'haenen H.  Brain Res. 2007; 1137(1): 111-116. IF 2009 = 2.463

6.Left and right High Frequency repetitive Transcranial Magnetic Stimulation of the dorsolateral prefrontal cortex does not affect mood in female volunteers Baeken C., Leyman L., De Raedt R., Vanderhasselt M.A. and D’haenen H. Clin Neurophysiol. 2008; 119(3): 568-575. IF 2009 = 3.122

7.The impact of one session of HF-rTMS on Salivary Cortisol in Healthy Female Subjects. Baeken C., De Raedt R., Leyman L., Schiettecatte J., Poppe K., Kaufman L., Haes M., Vanderhasselt M.A., Anckaert E. and D’haenen H. World Journal of Biological Psychiatry. 2009; 10: 586-590. IF 2009 = 5.564

9.A single session of rTMS over the left dorsolateral prefrontal cortex influences attentional control in depressed patients. Vanderhasselt MA, de Raedt R, Baeken C, Leyman L, D'haenen H. World J Biol Psychiatry. 2009, 10(1): 34-42. IF 2009 = 5.564

10.The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients. Baeken C, De Raedt R, Leyman L, Schiettecatte J, Kaufman L, Poppe K, Vanderhasselt MA, Anckaert E, Bossuyt A. J Affect Disord. 2009; 113(1-2): 100-108. IF 2009 = 3.763

11.Influence of high-frequency repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex on the inhibition of emotional information in healthy volunteers. Leyman L, De Raedt R, Vanderhasselt MA, Baeken C. Psychol Med. 2009; 39(6): 1019-1028. IF 2009 = 5.012

12.Acute effects of repetitive transcranial magnetic stimulation on attentional control are related to antidepressant outcomes. Vanderhasselt MA, De Raedt R, Leyman L, Baeken C. J Psychiatry Neurosci. 2009; 34(2): 119-126. IF 2009 = 3.579

13.Dorsolateral prefrontal cortex and Stroop performance: Tackling the lateralization. Vanderhasselt MA, De Raedt R, Baeken C. Psychonomic Bulletin and Review. 2009; 16(3): 609-612. IF 2009 = 1.44

14.HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. Chris Baeken, Rudi De Raedt, Christian Van Hove, Peter Clerinx, Johan De Mey and Axel Bossuyt. CNS Spectrums 2009; 14(8): 439-448. IF 2009 = 3.409

15.Amygdala responses to positively and negatively valenced baby faces in healthy female volunteers: influences of individual differences in Harm Avoidance. Chris Baeken, Rudi De Raedt, Nick Ramsey, Peter Van Schuerbeek, Dora Hermes, Axel Bossuyt, Lemke Leyman, Marie-Anne Vanderhasselt, Johan De Mey, Robert Luypaert. Brain Research. 2009; 1296: 94-103. IF 2009 = 2.463

16.Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research. Peleman K, Van Schuerbeek P, Luypaert R, Stadnik T, De Raedt R, De Mey J, Bossuyt A, Baeken C. World J Biol Psychiatry. 2010. 11(2 Pt 2): 425-430. IF 2009 = 5.564

17.A ´hypersensitive´ HPA-system could be indicative for a negative clinical HF-rTMS outcome in melancholic depressed patients. Baeken C., De Raedt R., Vanderhasselt MA., Leyman L., Schiettecatte J., Poppe K., Anckaert E. and Bossuyt A. Brain Stimulation. 2010; 3 (1): 54-57. IF 2009 = 3.000

18.The role of the left DLPFC in endogenous task preparation: an experimental repetitive Transcranial Magnetic Stimulation study. Vanderhasselt, M.A., De Raedt, C, Leyman, L., R., Baeken, C. Neuropsychobiology. 2010; 61:162-168. IF 2009 = 2.147

19.Acute Relapse after successful VNS Therapy: a case report of last resort ECT Treatment. Liesbeth Santermans, Nathalie Vanderbruggen, Chris Baeken. The Primary Care Companion to the Journal of Clinical Psychiatry. 2010, 12(3) e1. IF 2009 = 5.218


20.Passively viewing negatively valenced baby faces attenuates left amygdala activity in healthy females scoring high on ‘Harm Avoidance’. Chris Baeken, Peter Van Schuerbeek, Rudi De Raedt, Axel Bossuyt, Marie-Anne Vanderhasselt, Johan De Mey, Robert Luypaert. Neuroscience Letters 2010; 478(2): 97-101. IF 2009 = 1.925

21.Right prefrontal HF-rTMS attenuates right amygdala processing of negatively valenced emotional stimuli in healthy females. C. Baeken, R. De Raedt, P. Van Schuerbeek, M.A. Vanderhasselt, J. De Mey, A. Bossuyt, R. Luypaert. Behavioural Brain Research. 2010, 214: 450–455. IF 2009 = 3.763

22.HF-rTMS treatment decreases psychomotor retardation in medication-resistant melancholic depression. Baeken C., De Raedt R., Santermans L. M.D., Zeeuws D., Vanderhasselt M.A., Meers M., Vanderbruggen N. Progress in Neuropsychopharmacology&Biological Psychiatry 2010; 34(4): 684-687. IF 2009 = 2.823

23.Reduced left Subgenual Anterior Cingulate Cortical activity during withdrawal-related Emotional Experiences in Melancholic Depressed female Patients. Chris Baeken, Peter Van Schuerbeek, Rudi De Raedt, Nick Ramsey, Axel Bossuyt, Johan De Mey, Marie-Anne Vanderhasselt, Lemke Leyman, Robert Luypaert. Journal of Affective Disorders. 2010 Dec;127(1-3):326-31. IF 2009 = 3.763

24.Neurocognitive effects of Hf-rTMS over the dorsolateral prefrontal cortex on the attentional processing of emotional information in healthy subjects: An event-related fMRI study. De Raedt, R., Leyman, L., Baeken, C., Van Schuerbeek, P., Luypaert, R., Vanderhasselt, M.A., & Dannlowski, U. (2010). Biol Psychol. 2010 Dec;85(3):487-95. IF 2009= 4.363

25.Baseline ‘state anxiety’ influences HPA-axis sensitivity to one sham-controlled HF-rTMS session applied to the right dorsolateral prefrontal cortex. Baeken C, Vanderhasselt MA., De Raedt R. Psychoneuroendocrinology.  2011 Jan;36(1):60-7. IF 2009 = 4.194

26.Effects of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex on the attentional processing of emotional information in major depression: A pilot study. Leyman L, De Raedt R, Vanderhasselt MA, Baeken C. Psychiatry Res. 2011 Jan 30;185(1-2):102-7.IF 2009 = 2.373

27.Intensive HF-rTMS treatment in an ECT resistant Bipolar I Patient in a mixed episode. Dieter Zeeuws M.D., Kim De Rycker M.D., Rudi De Raedt, Ph.D., Matthieu De Beyne M.D., Chris Baeken M.D., Ph.D., Nathalie Vanderbruggen M.D. Brain Stimulation. 2011 Jan;4(1):46-9. IF 2009 = 3.000

28.Individual differences in local gray and white matter volumes reflect differences in temperament and character: a voxel-based morphometry study in healthy young females. Peter Van Schuerbeek; Chris Baeken; Rudi De Raedt; Johan De Mey; Rob Luypaert. Behavioural Brain Research. 2011 Jan 31; 1371:32-42. IF 2009 = 2.463

29.Intensive rTMS applications in difficult to treat psychiatric patients: some cases. Zeeuws D, Santermans L, Baeken C, Vanderbruggen N. Psychiatr Danub. 2010 Nov;22 Suppl 1:S135-6. IF 2009 = 0.702

30.The impact of HF-rTMS treatment on Serotonin 2A receptors in Unipolar Depression. C.Baeken, R. De Raedt, A. Bossuyt, C. Van Hove, J. Mertens, A. Dobbeleir, P. Blanckaert, and I. Goethals. Brain Stimulation, 2011 Apr;4(2):104-11. IF 2009= 3.000

31.Neurobiological mechanisms of Repetitive Transcranial Magnetic Stimulation on the Underlying Neurocircuitry in Unipolar Depression. Baeken C., De Raedt R. Dialogues in Clinical Neuroscience 2011;13(1):139-45.

32.The Effects of High Frequency rTMS on Negative Attentional Bias are Influenced by Baseline State Anxiety. Vanderhasselt, M.A., Baeken, C., Hendrickx, M., & De Raedt, R. Neuropsychologia, 2011 Jun;49(7):1824-30. IF 2009= 4.766

33.The effect of one left-sided dorsolateral prefrontal sham-controlled HF-rTMS session on approach and withdrawal related emotional neuronal processes. C. Baeken, P. Van Schuerbeek, R. De Raedt, J. De Mey, M.A. Vanderhasselt, A. Bossuyt, R. Luypaert. Clin. Neurophysiology, 2011 Nov;122(11):2217-26. IF 2009 = 3.122.

34.No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Herremans S, Baeken C, Vanderbruggen N, Vanderhasselt MA, Zeeuws D, Santermans L, De Raedt R. Drug and Alcohol Dependence, 2012 Jan 1;120(1-3):209-13. IF 2009= 3.599

35.Is treatment-resistance in unipolar melancholic depression characterized by decreased serotonin 2A receptors in the dorsal prefrontal - anterior cingulate cortex? Chris Baeken, Rudi De Raedt and Axel Bossuyt. Neuropharmacology 2012 Jan;62(1):340-6. IF 2009= 3.909

36.Impact of One HF-rTMS Session on Fine Motor Function in Right-Handed Healthy Female Subjects: A Comparison of Stimulation over the Left versus the Right Dorsolateral Prefrontal Cortex. Baeken C, Schrijvers DL, Sabbe BG, Vanderhasselt MA, De Raedt R. Neuropsychobiology. 2012 Jan 17;65(2):96-102. IF 2009 = 2.147

37.Parsing the components of the psychomotor syndrome in schizophrenia. Lise Docx, Manuel Morrens, Chris Bervoets, Wouter Hulstijn, Marc De Hert, Chris Baeken, Kurt Audenaert, Bernard Sabbe. Acta Psychiatrica Scandinavica.in press



38.Inter-individual differences in the habitual use of cognitive reappraisal and expressive suppression are associated with variations in prefrontal cognitive control for emotional information: An event related fMRI study. Vanderhasselt, M.A., Baeken,C., Van Schuerbeek,P., Luypaert, R., & De Raedt, R. Biol Psychology. In press

39.The influence of emotional priming on the neural substrates of memory: A prospective fMRI study using portrait art stimuli. Chris Baeken, Rudi De Raedt, Peter Van Schuerbeek, Johan De Mey, Axel Bossuyt, Robert Luypaert. NeuroImage. 2012 Mar 23;61 (4):876-883.

40.Stress sensitive healthy females show less left amygdala activation in response to withdrawal-related visual stimuli under passive viewing conditions. Chris Baeken, Peter Van Schuerbeek, Rudi De Raedt, Marie-Anne Vanderhasselt, Johan De Mey, Axel Bossuyt, Robert Luypaert. Brain & Cognition. In press.

41.The impact of high frequency repetitive Transcranial Magnetic Stimulation on fine motor functions in medication resistant major depression. Schrijvers Didier, Baeken Chris, De Raedt Rudi, Sabbe Bernard. In press.

 

PrintEmail

BCNBP

UPC KU Leuven, Campus Gasthuisberg,
Herestraat 49,
3000 Leuven

VAT BE 0415.048.548

BECOME A MEMBER